User name

Don't have a user name yet?
Register here.


Lek planning EUR 83m investment in Ljubljana

Ljubljana, 29 January - Lek, a Novartis-owned Slovenian drug maker, is planning an EUR 82.6 million investment in Ljubljana to set up a new production facility for liquid vials and pre-filled syringes. The government is expected to subsidise it with EUR 6.56 million, according to working documents prepared for government sessions.

Lek HQ in Ljubljana
Photo: Tamino Petelinšek/STA
File photo

The rest of this news item is available to subscribers.
The news item consists of 652 characters (without spaces) or 124 words words.

Buy the news item. Price: 2 tokens; on account: 0 tokens.

© STA, 2022